Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VCT220 in Non-diabetic Overweight/Obese Adults
CTR20233978Phase 2Completed
- Sponsor
- Suzhou Wentai Pharmaceutical Technology
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VCT220 in obesity, Overweight, sponsored by Suzhou Wentai Pharmaceutical Technology. Started Dec 2023; status: completed.
02
Drugs
VCT220
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20233978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233978.